FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Publications
  • Links
  • News
✕
Published by Austin on March 16, 2022
Categories

Augenklinik

  • DateMarch 16, 2022
  • Executive Board
  • Research Groups
  • Central Projects
  • Associated projects
  • Alumni

Curriculum Vitae

Dr. rer. nat. Anne Wolf

Department of Ophthalmology
Experimental Immunology of the Eye
University of Cologne
Kerpener Straße 62
50937 Cologne, GERMANY

Visitor’s Address:
Building 35 (Anatomy)
Joseph-Stelzmann-Str. 9
50931 Cologne, GERMANY

Scientific career

2015- Affiliated PhD student in Project 6 “Role of the complement system and microglia in age-related macular degeneration” in the DFG Research Unit FOR 2240 “Angiogenesis, Lymphangiogenesis and Cellular Immunity in Inflammatory Diseases of the Eye” at the Department of Ophthalmology, University of Cologne

2018- Affiliated PhD student in Project 6 “Role of complement receptors and microglia in age-related macular degeneration” in the DFG Research Unit FOR 2240 “Angiogenesis, Lymphangiogenesis and Cellular Immunity in Inflammatory Diseases of the Eye” at the Department of Ophthalmology, University of Cologne

2020- PostDoc and Lableader, Experimental Immunology of the eye, University of Cologne

2022- Member of the International Society of Eye Research: ISER

2022- Editorial Board, Cellular Neuropathology (Frontiers in Cellular Neuroscience)

Prizes and honors

2018 Pro Retina Travel Award

2019 IPaK Travel Award

2019 Retina Suisse Award

2022 German Research Program for Ophthalmology, Bayer

Selected publications

Tabel, M., Wolf, A., Szczepan, M., Xu, H-, Jagle, H., Moehle, C., Chen, M., Langmann, T. (2022) Genetic targeting or pharmacological inhibition of galectin-3 dampens microglia reactivity and delays retinal degeneration. J Neuroinflammation. 19(1):229

Kinuthia, U. M., Wolf, A., & Langmann, T. (2020). Microglia and Inflammatory Responses in Diabetic Retinopathy. Frontiers in Immunology, 11(2888). doi:10.3389/fimmu.2020.564077

Wolf, A., Herb, M., Schramm, M., & Langmann, T. (2020). The TSPO-NOX1 axis controls phagocyte-triggered pathological angiogenesis in the eye. Nat Commun, 11(1), 2709.

Behnke, V., Wolf, A., & Langmann, T. (2020). The role of lymphocytes and phagocytes in age-related macular degeneration (AMD). Cell Mol Life Sci, 77(5), 781-788.

Wolf, A., & Langmann, T. (2019). Anti-VEGF-A/ANG2 combotherapy limits pathological angiogenesis in the eye: a replication study. EMBO Mol Med, 11(5).

Herb, M., Gluschko, A., Wiegmann, K., Farid, A., Wolf, A., Utermohlen, O., Krug, O., Krönke, M., Schramm, M. (2019). Mitochondrial reactive oxygen species enable proinflammatory signaling through disulfide linkage of NEMO. Sci Signal, 12(568).

Balser, C. and Wolf, A. (first co-authorship), Herb, M., & Langmann, T. (2019). Co-inhibition of PGF and VEGF blocks their expression in mononuclear phagocytes and limits neovascularization and leakage in the murine retina. J Neuroinflammation, 16(1), 26.

Rashid, K., Geissl, L., Wolf, A., Karlstetter, M., & Langmann, T. (2018). Transcriptional regulation of Translocator protein (18kDa) (TSPO) in microglia requires Pu.1, Ap1 and Sp factors. Biochim Biophys Acta Gene Regul Mech, 1861(12), 1119-1133.

Rashid, K., Wolf, A., & Langmann, T. (2018). Microglia Activation and Immunomodulatory Therapies for Retinal Degenerations. Front Cell Neurosci, 12, 176

Wolf, A., Aslanidis, A., & Langmann, T. (2017). Retinal expression and localization of Mef2c support its important role in photoreceptor gene expression. Biochem Biophys Res Commun, 483(1), 346-351.

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Claudia Bock
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
claudia.bock@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck
      Um unsere Website für Sie optimal zu gestalten und fortlaufend verbessern zu können, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Weitere Informationen zu Cookies und insb. der Möglichkeiten, der Verwendung von Cookies zu widersprechen, erhalten Sie in unserer Datenschutzerklärung.SchließenDatenschutzerklärung